[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![beingsoldeus Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1934257229924036608.png) Swarnava Mazumder [@beingsoldeus](/creator/twitter/beingsoldeus) on x XX followers
Created: 2025-07-23 03:25:00 UTC

The GLP-1 surge in India is a game-changer! Obesity affects 254M, and with 2026 patent expiry, generics like semaglutide (Wegovy) could tap a $10B market. Firms like Dr. Reddy’s lead, but high costs and access gaps need addressing for equitable health impact.


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947860473279553785/c:line.svg)

**Related Topics**
[asset management](/topic/asset-management)
[dr reddys](/topic/dr-reddys)
[$10b](/topic/$10b)
[wegovy](/topic/wegovy)
[india](/topic/india)
[surge](/topic/surge)

[Post Link](https://x.com/beingsoldeus/status/1947860473279553785)